NASDAQCommunication ServicesAdvertising AgenciesSnapshot 2026-10-23
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
A matching fiscal period and sufficient coverage are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least five analysts and a baseline within three days of the requested lookback.
| Measure / period | Management expectations | Analyst expectations |
|---|---|---|
| Quarter ending 2026-12-30 | ||
| Revenue | — | 11.24M |
| EPS | — | 0.02 |
Management figures unavailable.
4 published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Move towards sustained profitability | A primary condition in Stran & Co Inc's published investment case. The stated target is Positive net income by end of 2026. | Improving | Net income remains negative through FY26 | Net income: $309,000 FY2026-Q2; GAAP. Published target: Positive net income by end of 2026. Target period is not explicitly aligned with this observation. Source published Aug 11, 2026309,000 USD · source valueSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 8a1fd4b0-c242-4fc5-bd5a-ce3405bdd23b. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 2 of last 2 quarters. Revenue grew from $28.7M in 2025-Q1 to $31.2M in 2026-Q1, with net income improving from a loss of $0.4M to a profit of $0.7M. Management’s statements and financial results show delivering sustained profitable growth in 2026. Delivery assessment Oct 24, 2026 |
Sustained revenue growth in 2026 | A primary condition in Stran & Co Inc's published investment case. The stated target is >=5% YoY revenue growth in 2026. | Intact | YoY revenue growth falls below 5% in FY26 | Revenue growth: 2.4% FY2026-Q2; GAAP. Published target: >=5% YoY revenue growth in 2026. Target period is not explicitly aligned with this observation. Source published Aug 11, 20262.397397 percent · calculatedSource reportLast status assessment Oct 24, 2026Measurement sourceconsolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: 8a1fd4b0-c242-4fc5-bd5a-ce3405bdd23b. Source status: eligible. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 2 of last 2 quarters. Revenue grew from $28.7M in 2025-Q1 to $31.2M in 2026-Q1, with net income improving from a loss of $0.4M to a profit of $0.7M. Management’s statements and financial results show delivering sustained profitable growth in 2026. Delivery assessment Oct 24, 2026 |
Completion of strategic acquisitions | A supporting condition in Stran & Co Inc's published investment case. The stated target is Complete at least 2 strategic acquisitions in 2026. | Intact | No strategic acquisitions completed in FY26 | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Source date unavailableLast status assessment Oct 24, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. Management contextStated as a priority in 3 of last 3 quarters with multiple acquisition completions announced. While financials show improving profitability, specific synergy impacts are not quantified yet. Management continues to emphasize acquisitions as a growth strategy with mixed delivery so far. Delivery assessment Oct 24, 2026 |
Valuation multiples normalize towards peers | The stock trades cheap versus peers despite high risk. | Intact | PE remains above 100 beyond 2027 without profit growth | P/E (TTM): 430.00x As of 2026-10-23; trailing twelve months. The target timing and basis require a separate assessment. Market data as of Oct 23, 2026430 ratio · calculatedLast status assessment Oct 24, 2026Measurement sourceconsolidated · TTM valuation Period ending Oct 23, 2026 Source: mart.stock_valuation_daily. Reference: SWAG:2026-10-23. Source status: canonical calculation. Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Sep 25–Oct 24 · 0 recorded
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Nov 11, 2026
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Review earnings4 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
SWAG is a high-risk growth and acquisition story, not yet a proven durable compounder, because it has only recently moved from a small loss to profit. Its long-term thesis is intact, but confidence has eased from high to medium and evidence on acquisition benefits remains mixed.
The valuation evidence is mixed and low-confidence: one measure points to a discount versus peers, while another shows a premium of about 21%. The priced-in assessment is tagged justified, with a negative expectations gap, suggesting the market is not assuming an easy path to success.
Near term, revenue growth and the move to a small profit support management’s stated goal of sustained profitable growth, while new agreements and extensions offer some evidence of client expansion. Acquisitions are ongoing, but their synergy benefits are not quantified, and the next results carry elevated miss risk; a guidance cut would be a meaningful setback.
Over the next one to three years, the thesis hinges on whether SWAG can sustain profitable growth, deepen client relationships, and show measurable benefits from acquisitions. Near-term conditions could be helped by rate cuts and continued strength among sector peers, while weaker guidance or execution would challenge the case.
The multi-year view is intact, supported by improving results, but it remains a high-risk story with mixed valuation signals and limited proof of acquisition benefits. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.